CAAS Capital Management’s Heron Therapeutics HRTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-175,333	Closed	-$2.72M	–	683
2021 Q2	$2.72M	Buy	+175,333	New	+$2.72M	0.05%	132